Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - CALMARE THERAPEUTICS Inc | Financial_Report.xls |
| 10-Q/A - COMPETITIVE TECHNOLOGIES, INC. AMENDMENT NO. 1 TO FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2012 - CALMARE THERAPEUTICS Inc | cttc10q3q2012a1.htm |
| EX-31 - EXHIBIT 31.1 - CALMARE THERAPEUTICS Inc | cttc10q3q2012x311.htm |
| EX-32 - EXHIBIT 32.2 - CALMARE THERAPEUTICS Inc | cttc10q3q2012x322.htm |
| EX-31 - EXHIBIT 31.2 - CALMARE THERAPEUTICS Inc | cttc10q3q2012x312.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Report of Competitive Technologies, Inc. (the "Company") on Amendment no. 1 to Form 10-Q for the period ended September 30, 2012, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Carl O’Connell, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:
1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ Carl O’Connell
Carl O’Connell
Chief Executive Officer
November 30, 2012
A signed original of this written statement required by Section 906 has been provided to Competitive Technologies and will be retained by Competitive Technologies and furnished to the Securities and Exchange Commission or its staff upon request.